Italian CF Society Offers Clinical Research Training to Physicians

International outsourcing services provider, CROMSOURCE, which works with pharmaceutical, biotech and medical device companies, is providing a series of training modules on the best practices for clinical research regarding specialized conditions, including cystic fibrosis (CF). The course is being organized by the Italian Cystic Fibrosis Society (SIFC) and is taking place until this February, according to a press release from the company.

The development of effective therapeutic options for the treatment of rare conditions such as CF rely primarily on the work of researchers and specialized clinics. Therefore, the course aims to increase clinicians’ capabilities to advance research projects and engage with patients under their care.

[adrotate group=”1″]

The SIFC believes that providing training for clinical research best practices to help physicians improve participation in clinical research programs and communication with CF patients is crucial. With this in mind, SIFC has partnered with CROMSOURCE, which leverages well-recognized experts in clinical research and has extensive experience in CF research, to conduct the training.

“We are delighted to take part in this initiative and work alongside representatives from the Italian ISS (National High Health Commission), the US Cystic Fibrosis Foundation, Ethics Committees and various pharmaceutical companies,” stated the founder and Chief Executive Officer of CROMSOURCE, Oriana Zerbini, MD. “CROMSOURCE is committed to sharing our expertise in clinical research and fully recognize the importance of this training course. In this spirit we have pleasure in supporting this important initiative.”

The course, which is being taught by CROMSOURCE personnel and will run until February, will train clinicians in subjects such as typical aspects of a clinical research study protocol, the responsibilities of the physician and clinical staff who are involved in clinical research, and the regulatory application and approval process for clinical research.

Working since 1994 in collaboration with medical institutions, CROMSOURCE has become one of the leading providers of outsourced services in several countries in both Europe and North America. The company’s expertise is based on clinical development and staffing solutions, and its services has been focused on supporting their clients unique projects.